About Baird
Families & Individuals
Corporations & Institutions
Baird Research & Insights
Contact Us
Client Login
Individuals - Baird OnLine
Institutions
Corporations & Institutions
Investment Banking
Recent Financing Transactions
Deal Card
Investment Banking
Conferences
Asset Management
Private Equity
Fixed Income Sales and Trading
Equity Sales and Trading
Executive Services
Public Finance
Corporate Services
Institutional Consulting
Contact Us
Mergers and Acquisitions
Equity Financing
Corporate Restructuring
Industries of Focus
Financial Sponsors
Team Bios
News
Investment Banking Accolades
M&A Expertise
M&A Services
M&A Recent Transactions
Equity Financing Expertise
Equity Financing Services
Recent Financing Transactions
Corporate Restructuring Expertise
Corporate Restructuring Services
Business Services
Clean Technology
Consumer
Distribution
Energy
Financial Services
Healthcare
Industrial
Real Estate
Technology
Utilities
Financial Sponsors Recent Transactions
Here's the Deal
Baird's Investment Banking Group is pleased to announce the following transaction:
October 2007
TomoTherapy Incorporated
Follow-on Offering
$217.5 Million
Robert W. Baird & Co. acted as co-manager on this transaction.
TomoTherapy Incorporated (NASDAQ: TTPY) recently announced a follow-on offering of 9,775,000 shares (including over-allotment option) of its common stock at $22.25 a share, for gross proceeds of $217.5 million. All the proceeds of this offering will be received by the selling shareholders.
TomoTherapy (the “Company”) develops, manufactures and sells the Hi Art system, an advanced and versatile radiation therapy system for the treatment of a wide range of cancer types. The Hi Art system combines integrated CT imaging with radiation therapy to deliver radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue, which the Company believes can lead to improved patient outcomes. The Hi Art system contains a linear accelerator, which is a device that generates external beam radiation that is used both to capture high quality, quantitative images and to deliver therapeutic radiation in a helical, or spiral, delivery pattern 360 degrees around the body.
The Hi Art system’s helical delivery pattern and imaging capabilities, combined with the system’s advanced treatment planning software and ability to precisely shape the beam delivering radiation, allow clinicians to locate and define the size, shape and density of tumors, maximize radiation delivered to diseased tissue, minimize radiation delivered to healthy tissue and measure the radiation dose actually received by the patient.
The Baird team included our dedicated Healthcare industry bankers and members of our Equity Capital Markets Group.
For additional information about this transaction, please contact:
Managing Director
(312) 609-4912
Vice President
(414) 298-6162
Careers
|
Help
|
Site Map
|
Important Disclosures
|
Privacy Policy
|
Financial Information
|
Business Continuity
©2013 Robert W. Baird & Co. Incorporated.
Global Websites:
Europe
|
Asia
The services featured on this Web site may not be available in all jurisdictions or to all persons/entities. For more information, please see
Important Disclosures
. Robert W. Baird & Co. Incorporated. Member
SIPC
.